Back to AZN Stock Lookup

AstraZeneca (AZN) –

Sep 26, 2016 12:13 PM Form 6-K ASTRAZENECA PLC For: Sep 26
Sep 23, 2016 07:11 AM Piper Jaffray Starts AstraZeneca (AZN) at Overweight
Sep 22, 2016 09:02 AM Form 6-K ASTRAZENECA PLC For: Sep 22
Sep 21, 2016 07:43 AM AstraZeneca (AZN) Withdraws App for Ovarian-Cancer Treatment in Europe
Sep 16, 2016 08:02 AM AstraZeneca (AZN) Announces Significant Data from Bydureon Combo Phase 3 in T2D Patients
Sep 16, 2016 08:00 AM Phase III Combination Trial of BYDUREON and FARXIGA Shows Significant Blood Sugar Reduction in Patients with Type 2 Diabetes
Sep 13, 2016 12:55 PM Exane BNP Paribas Downgrades AstraZeneca (AZN) to Neutral
Sep 12, 2016 06:42 AM Jefferies Upgrades AstraZeneca (AZN) to Buy
Sep 6, 2016 11:03 AM Avara to Acquire AstraZeneca's (AZN) Avlon, England-Located Manufacturing Facility
Sep 6, 2016 07:48 AM AstraZeneca (AZN) Announces SIROCCO, CALIMA Trials Met Primary, Key Secondary Endpoints
Sep 5, 2016 08:00 AM Benralizumab Phase III Trials Show Positive Results in Severe Asthma
Sep 1, 2016 12:44 PM Form 6-K ASTRAZENECA PLC For: Sep 01
Sep 1, 2016 08:22 AM Form 6-K ASTRAZENECA PLC For: Sep 01
Aug 31, 2016 05:02 PM AstraZeneca (AZN) Announces Statistical, non-Inferiority SYMBICORT Safety Study Data in Asthma Exacerbations
Aug 31, 2016 05:00 PM AstraZeneca Announces SYMBICORT Demonstrated Comparable Risk of Serious Asthma-Related Events and Lower Risk of Asthma Exacerbations Compared to Budesonide Alone
Aug 29, 2016 08:09 AM Argus Upgrades AstraZeneca (AZN) to Buy
Aug 26, 2016 12:14 PM AstraZeneca (AZN) Announces Several Executive Changes; Luke Miels Becomes EVP of Europe - Bloomberg
Aug 24, 2016 08:25 PM Global markets subdued ahead of Yellen speech, healthcare stocks dip
Aug 24, 2016 06:19 AM Form 6-K ASTRAZENECA PLC For: Aug 24
Aug 24, 2016 06:05 AM Pfizer (PFE) Enters Agreement to Acquire AstraZeneca's (AZN) Small Molecule Anti-Infective Business in ~$1.58B Deal
Aug 22, 2016 06:09 AM Eli Lilly & Co. (LLY), AstraZeneca (AZN) Receive FDA Fast Track Designation for AZD3293 as BACE Inhibitor
Aug 18, 2016 08:53 AM Form 6-K ASTRAZENECA PLC For: Aug 18
Aug 16, 2016 07:45 AM Form 6-K ASTRAZENECA PLC For: Aug 16
Aug 16, 2016 07:10 AM Adherium, AstraZeneca (AZN) Enter Smartinhaler Platform Supply Agreement
Aug 10, 2016 12:38 PM Form 6-K ASTRAZENECA PLC For: Aug 10
Aug 10, 2016 09:45 AM AstraZeneca (AZN) Announces Positive Data from Two SYMBICORT Studies; Primary Endpoints Met
Aug 9, 2016 06:28 AM Form 6-K ASTRAZENECA PLC For: Aug 09
Aug 9, 2016 05:49 AM AstraZeneca (AZN) Reports Selumetinib Phase 3 Missed Primary Endpoint in NSCLC (ARRY)
Aug 9, 2016 02:01 AM AstraZeneca Provides Update On Phase III Trial Of Selumetinib In Non-Small Cell Lung Cancer
Aug 5, 2016 03:18 PM Notable 52-Week Highs and Lows 8/5: (MRK) (MTZ) (AZN) High; (CPSI) (BBRG) (APRI) Low
Aug 5, 2016 10:43 AM AstraZeneca hits 2014 Pfizer bid price, helped by Bristol's woes
Aug 5, 2016 08:24 AM Merck (MRK) Surges After Bristol-Myers Squibb's (BMY) CheckMate -026 Trial Fails
Aug 1, 2016 11:58 AM Form 6-K ASTRAZENECA PLC For: Aug 01
Aug 1, 2016 11:41 AM Form 6-K ASTRAZENECA PLC For: Aug 01
Jul 28, 2016 02:52 PM AstraZeneca (AZN) August calls active after declined comment on takeover speculation, report
Jul 28, 2016 12:29 PM Form 6-K ASTRAZENECA PLC For: Jul 28
Jul 28, 2016 08:13 AM AstraZeneca (AZN) Tops Q2 EPS by 7c
Jul 28, 2016 06:42 AM AstraZeneca (AZN) sees $40 - $41 billion in sales by 2023 - Bloomberg, citing CEO Soriot
Jul 27, 2016 07:51 AM Form 6-K ASTRAZENECA PLC For: Jul 27
Jul 20, 2016 11:05 AM Mylan (MYL) Announces U.S. Launch of Generic Crestor
Jul 19, 2016 04:29 PM Valeant Pharma (VRX) Announces FDA AdCom Recommendation of Brodalumab as Plaque Psoriasis Treatment
Jul 19, 2016 04:27 PM FDA Advisory Committee Recommends Approval Of Brodalumab For Treatment Of Moderate-To-Severe Plaque Psoriasis
Jul 19, 2016 01:01 PM Form 6-K ASTRAZENECA PLC For: Jul 19
Jul 18, 2016 07:51 AM Form 6-K ASTRAZENECA PLC For: Jul 18
Jul 18, 2016 07:13 AM AstraZeneca (AZN) Announces AURA3 Phase III Met Primary Endpoint in 2nd-Line Lung Cancer Trial
Jul 18, 2016 07:12 AM TAGRISSO® (OSIMERTINIB) Met Primary Endpoint in Phase III 2nd-Line Lung Cancer Trial
Jul 12, 2016 07:42 AM Argus Starts AstraZeneca (AZN) at Hold
Jul 5, 2016 08:25 AM Pfizer's (PFE) 'Stalking Horse Bid' Leaves Little Room for BIND Therapeutics' (BIND) Holders -Stifel
Jul 1, 2016 12:43 PM Form 6-K ASTRAZENECA PLC For: Jul 01
Jul 1, 2016 06:18 AM Form 6-K ASTRAZENECA PLC For: Jul 01

Back to AZN Stock Lookup